Acquisition Announced
GSK acquisition of 35Pharma
US$950m consideration
Announced 25 Feb 2026
Advisers
35Pharma
Target
- Financial adviser
GSK
Acquirer
- Target
- 35Pharma
- Acquirer
- GSK
- Target based in
- Canada
- Buyer based in
- United Kingdom
- Sector
- Biotech
- Tags
- Biotech, Drug Development
Similar deals
- Amgen acquisition of Dark Blue Therapeutics Jan 2026 · US$840m · Biotech
- Jazz Pharmaceuticals acquisition of Actio Biosciences Aug 2026 · US$820m · Biotech
- BioCryst Pharmaceuticals acquisition of Astria Therapeutics Oct 2025 · US$700m · Biotech
- GSK acquisition of trispecific T cell-engager (TCE) asset Sep 2026 · US$750m · Biotech
- Incyte acquisition of Vega Therapeutics Jun 2026 · US$1.3bn · Biotech
Sources
- 2026 Centerview Partners: Lead financial advisor to 35Pharma on its sale to GSK centerviewpartners.com
- 25 Feb 2026 GSK to Acquire 35Pharma paulweiss.com
- 25 Feb 2026 35Pharma Enters Agreement to Be Acquired by GSK cooley.com

